Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fasted Conditions
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
- Objective:
- Compare the bioequivalence of a test topiramate formulation (Torrent
Pharmaceuticals Limited) to an equivalent oral dose of the commercially available
topiramate (Topamax®, Ortho-McNeil Neurologics, Inc.) in a test population of 26
adult subjects under fasted conditions.
- Clinical Design:
- Studies were Randomized, Two-Way Crossover, Single-Dose,Open-Label in healthy human
adult subjects.